Published in Biochim Biophys Acta on January 07, 1983
Alveolar epithelial type II cell: defender of the alveolus revisited. Respir Res (2001) 3.26
Nucleotide and amino acid sequences of pulmonary surfactant protein SP 18 and evidence for cooperation between SP 18 and SP 28-36 in surfactant lipid adsorption. Proc Natl Acad Sci U S A (1987) 2.43
Altered surfactant homeostasis and alveolar type II cell morphology in mice lacking surfactant protein D. Proc Natl Acad Sci U S A (1998) 2.22
Pulmonary surfactant and its components inhibit secretion of phosphatidylcholine from cultured rat alveolar type II cells. Proc Natl Acad Sci U S A (1987) 1.79
Pulmonary surfactant and its apoproteins. J Clin Invest (1990) 1.55
Infrared spectroscopic investigations of pulmonary surfactant. Surface film transitions at the air-water interface and bulk phase thermotropism. Biophys J (1989) 1.18
Lung surfactant apoprotein SP-A (26-36 kDa) binds with high affinity to isolated alveolar type II cells. Proc Natl Acad Sci U S A (1989) 1.13
Surfactant therapy for acute lung injury and acute respiratory distress syndrome. Crit Care Clin (2011) 1.04
Toxic oxidant species and their impact on the pulmonary surfactant system. Lung (1997) 1.01
Phosphorylcholine stimulates capsule formation of phosphate-limited mucoid Pseudomonas aeruginosa. Infect Immun (1988) 1.00
Degradation of surfactant-associated protein B (SP-B) during in vitro conversion of large to small surfactant aggregates. Biochem J (1993) 0.98
Patients with ARDS show improvement but not normalisation of alveolar surface activity with surfactant treatment: putative role of neutral lipids. Thorax (2007) 0.97
Surfactant for pediatric acute lung injury. Pediatr Clin North Am (2008) 0.94
Complexing of bacterial lipopolysaccharide with lung surfactant. Infect Immun (1986) 0.91
Roles of three transporters, CbcXWV, BetT1, and BetT3, in Pseudomonas aeruginosa choline uptake for catabolism. J Bacteriol (2011) 0.91
Surface-area cycling of different surfactant preparations: SP-A and SP-B are essential for large-aggregate integrity. Biochem J (1994) 0.89
Surface properties, morphology and protein composition of pulmonary surfactant subtypes. Biochem J (1996) 0.85
The relationship between intra- and extra-cellular surfactant phospholipids in the lungs of rabbits and the effects of silica-induced lung injury. Biochem J (1986) 0.84
Ozone stress initiates acute perturbations of secreted surfactant membranes. Am J Pathol (1991) 0.82
Altered lipid synthesis in type II pneumonocytes exposed to lung surfactant. Biochem J (1986) 0.80
Optical measurement of surface tension in a miniaturized air-liquid interface and its application in lung physiology. Biophys J (2005) 0.80
Surfactant-associated protein A is important for maintaining surfactant large-aggregate forms during surface-area cycling. Biochem J (1996) 0.79
Delivery and performance of surfactant replacement therapies to treat pulmonary disorders. Ther Deliv (2013) 0.78
Effects of smoke inhalation on surfactant phospholipids and phospholipase A2 activity in the mouse lung. Am J Pathol (1991) 0.77
Pneumocytes Assemble Lung Surfactant as Highly Packed/Dehydrated States with Optimal Surface Activity. Biophys J (2015) 0.77
Uptake of lectins by pulmonary alveolar type II cells: subsequent deposition into lamellar bodies. Proc Natl Acad Sci U S A (1984) 0.77
Effects of smoke inhalation on alveolar surfactant subtypes in mice. Am J Pathol (1994) 0.76
Transient in utero disruption of cystic fibrosis transmembrane conductance regulator causes phenotypic changes in alveolar type II cells in adult rats. BMC Cell Biol (2009) 0.75
Replacement of surfactant in hyaline membrane disease. Br Med J (Clin Res Ed) (1984) 0.75
Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab (2001) 4.47
Potassium permanganate reaction in amyloidosis. A histologic method to assist in differentiating forms of this disease. Lab Invest (1977) 4.21
Bone marrow-derived cells as progenitors of lung alveolar epithelium. Development (2001) 4.13
An improved method for isolating type II cells in high yield and purity. Am Rev Respir Dis (1986) 3.80
Neonatal pulmonary ischemia. I. Clinical and physiological studies. Pediatrics (1967) 3.60
Lipid transport in liver. I. Electron microscopic identification of very low density lipoproteins in perfused rat liver. Lab Invest (1967) 2.72
Sec6/8 complexes on trans-Golgi network and plasma membrane regulate late stages of exocytosis in mammalian cells. J Cell Biol (2001) 2.69
Disruption of LDL receptor gene in transgenic SREBP-1a mice unmasks hyperlipidemia resulting from production of lipid-rich VLDL. J Clin Invest (1999) 2.66
Research evaluation and diagnosis of probable Alzheimer's disease over the last two decades: I. Neurology (2000) 2.64
Isolation of disaturated phosphatidylcholine with osmium tetroxide. J Lipid Res (1976) 2.63
Surfactant proteins a and d and pulmonary host defense. Annu Rev Physiol (2001) 2.61
Assessment of the risk of the respiratory-distress syndrome by a rapid test for surfactant in amniotic fluid. N Engl J Med (1972) 2.56
Type II transmembrane serine proteases. Insights into an emerging class of cell surface proteolytic enzymes. J Biol Chem (2001) 2.56
Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice. J Clin Invest (1999) 2.50
Nucleotide and amino acid sequences of pulmonary surfactant protein SP 18 and evidence for cooperation between SP 18 and SP 28-36 in surfactant lipid adsorption. Proc Natl Acad Sci U S A (1987) 2.43
Kinetics of acetaminophen absorption and gastric emptying in man. Clin Pharmacol Ther (1978) 2.41
Lung surfactant. Biochim Biophys Acta (1974) 2.23
Altered surfactant homeostasis and alveolar type II cell morphology in mice lacking surfactant protein D. Proc Natl Acad Sci U S A (1998) 2.22
Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS. Am J Respir Crit Care Med (1999) 2.20
Apoprotein composition of very low density lipoproteins of human serum. J Clin Invest (1975) 2.18
Effects of a surfactant-associated protein and calcium ions on the structure and surface activity of lung surfactant lipids. Biochemistry (1985) 2.17
Characterization of remnants produced during the metabolism of triglyceride-rich lipoproteins of blood plasma and intestinal lymph in the rat. J Clin Invest (1975) 2.15
Discoidal bilayer structure of nascent high density lipoproteins from perfused rat liver. J Clin Invest (1976) 2.14
Left ventricular volume from paired biplane two-dimensional echocardiography. Circulation (1979) 2.08
The major lung surfactant protein, SP 28-36, is a calcium-dependent, carbohydrate-binding protein. J Biol Chem (1987) 2.05
Cloning, characterization, and development expression of a rat lung alveolar type I cell gene in embryonic endodermal and neural derivatives. Dev Biol (1995) 2.05
Surfactant protein D stimulates phagocytosis of Pseudomonas aeruginosa by alveolar macrophages. Am J Respir Cell Mol Biol (1999) 2.04
Surface active materials from dog lung. II. Composition and physiological correlations. Am J Physiol (1972) 2.03
Monoclonal antibodies specific to apical surfaces of rat alveolar type I cells bind to surfaces of cultured, but not freshly isolated, type II cells. Biochim Biophys Acta (1988) 2.01
Yellow fever immunity surveys in northern Uganda and Kenya and eastern Somalia, 1966-67. Bull World Health Organ (1968) 1.96
Resistance to diet-induced hypercholesterolemia and gallstone formation in ACAT2-deficient mice. Nat Med (2000) 1.94
Freeze-fracture identification of sterol-digitonin complexes in cell and liposome membranes. J Cell Biol (1978) 1.90
Concentration and composition of lipoproteins in blood plasma of the WHHL rabbit. An animal model of human familial hypercholesterolemia. Arteriosclerosis (1983) 1.90
Salivary agglutinin, which binds Streptococcus mutans and Helicobacter pylori, is the lung scavenger receptor cysteine-rich protein gp-340. J Biol Chem (2000) 1.89
Surfactant apoprotein Mr = 26,000-36,000 enhances uptake of liposomes by type II cells. J Biol Chem (1987) 1.88
A captive bubble method reproduces the in situ behavior of lung surfactant monolayers. J Appl Physiol (1985) (1989) 1.87
Direct determination of surface tension in the lung. Proc Natl Acad Sci U S A (1976) 1.83
The captive bubble method for the evaluation of pulmonary surfactant: surface tension, area, and volume calculations. Biochim Biophys Acta (1994) 1.81
Functions of the alveolar lining. Am Rev Respir Dis (1977) 1.81
Subcellular localization of B apoprotein of plasma lipoproteins in rat liver. J Cell Biol (1976) 1.81
X-34, a fluorescent derivative of Congo red: a novel histochemical stain for Alzheimer's disease pathology. J Histochem Cytochem (2000) 1.81
Isolation of a Golgi apparatus-rich fraction from rat liver. I. Method and morphology. J Cell Biol (1970) 1.80
[Studies on yellow fever in Ethiopia. 2. Serological study of the human population]. Bull World Health Organ (1968) 1.80
Pulmonary surfactant and its components inhibit secretion of phosphatidylcholine from cultured rat alveolar type II cells. Proc Natl Acad Sci U S A (1987) 1.79
A simple and inexpensive membrane "lung" for small organ perfusion. J Lipid Res (1974) 1.79
Relationship of amyloid to aging. Review of the literature and systematic study of 83 patients derived rom a general hospital population. Medicine (Baltimore) (1969) 1.79
Surfactant protein D enhances bacterial antigen presentation by bone marrow-derived dendritic cells. Am J Physiol Lung Cell Mol Physiol (2001) 1.78
Epidermal growth factor receptor expression and gene amplification in high-grade non-brainstem gliomas of childhood. Clin Cancer Res (1999) 1.76
Transepithelial transport by pulmonary alveolar type II cells in primary culture. Proc Natl Acad Sci U S A (1982) 1.75
Membrane sterol heterogeneity. Freeze-fracture detection with saponins and filipin. J Histochem Cytochem (1979) 1.74
Absorption, distribution and elimination of mexiletine. Postgrad Med J (1977) 1.74
Pharmacokinetics and analgesic effects of i.m. and oral ketamine. Br J Anaesth (1981) 1.71
Normal serum ferritin concentrations in precirrhotic hemochromatosis. N Engl J Med (1976) 1.68
Sudden death from fulminant acute cerebellitis. Pediatr Neurosurg (2001) 1.68
Human pulmonary surfactant protein (SP-A), a protein structurally homologous to C1q, can enhance FcR- and CR1-mediated phagocytosis. J Biol Chem (1989) 1.64
Unilamellar liposomes made with the French pressure cell: a simple preparative and semiquantitative technique. J Lipid Res (1980) 1.64
Alveolar lining layer is thin and continuous: low-temperature scanning electron microscopy of rat lung. J Appl Physiol (1985) (1995) 1.61
Characterization of lipoprotein particles isolated from the Golgi apparatus of rat liver. J Lipid Res (1969) 1.59
Aspergillosis in four renal transplant recipients. Diagnosis and effective treatment with amphotericin B. Ann Intern Med (1972) 1.58
Structural and metabolic heterogeneity of beta-very low density lipoproteins from cholesterol-fed dogs and from humans with type III hyperlipoproteinemia. J Lipid Res (1982) 1.57
Research evaluation and diagnosis of possible Alzheimer's disease over the last two decades: II. Neurology (2000) 1.57
Changes in lipid structure produced by surfactant proteins SP-A, SP-B, and SP-C. Am J Respir Cell Mol Biol (1991) 1.57
Metabolism and turnover of lung surfactant. Am Rev Respir Dis (1987) 1.56
Conversion of lamellar body membranes into tubular myelin in alveoli of fetal rat lungs. J Cell Biol (1977) 1.55
Aortic stenosis, atherosclerosis, and skeletal bone: is there a common link with calcification and inflammation? Eur Heart J (2013) 1.55
Pulmonary surfactant and its apoproteins. J Clin Invest (1990) 1.55
Clinical pharmacokinetics of paracetamol. Clin Pharmacokinet (1982) 1.54
Permeability of muscle capillaries to microperoxidase. J Cell Biol (1978) 1.54
Clinical-pathologic differentiation of common amyloid syndromes. Medicine (Baltimore) (1981) 1.53
Knockout of the abetalipoproteinemia gene in mice: reduced lipoprotein secretion in heterozygotes and embryonic lethality in homozygotes. Proc Natl Acad Sci U S A (1998) 1.53
Cholestasis: lamellar structure of the abnormal human serum lipoprotein. Science (1971) 1.51
Normotriglyceridemic abetalipoproteinemia. absence of the B-100 apolipoprotein. J Clin Invest (1981) 1.50
Isolation of apoproteins from canine surface active material. Am J Physiol (1973) 1.49
Pulmonary surface film stability and composition. J Appl Physiol Respir Environ Exerc Physiol (1979) 1.48
Evaluation of pressure-driven captive bubble surfactometer. J Appl Physiol (1985) (1994) 1.48
In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine. Diabet Med (2008) 1.46
Surfactant-associated protein A inhibits LPS-induced cytokine and nitric oxide production in vivo. Am J Physiol Lung Cell Mol Physiol (2000) 1.45
Age and TP53 mutation frequency in childhood malignant gliomas: results in a multi-institutional cohort. Cancer Res (2001) 1.45
Acute renal failure in multiple myeloma. Medicine (Baltimore) (1975) 1.43
Fetal abdominal circumference measurements of 35 and 38 cm as predictors of macrosomia. A risk factor for shoulder dystocia. J Reprod Med (2000) 1.43
Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque. Arterioscler Thromb (1994) 1.42
Recombinant rat surfactant-associated protein D inhibits human T lymphocyte proliferation and IL-2 production. J Immunol (1998) 1.42
Temperature dependence of dipalmitoyl phosphatidylcholine monolayer stability. J Appl Physiol Respir Environ Exerc Physiol (1981) 1.41
Ontogeny of tracheal fluid, pulmonary surfactant, and plasma corticoids in the fetal lamb. J Appl Physiol (1975) 1.41
Identification and characterization of human surfactant protein A binding protein of Mycoplasma pneumoniae. Infect Immun (2005) 1.41
Simplified radioimmunoassay for serum aldosterone utilizing increased antibody specificity. J Clin Endocrinol Metab (1974) 1.40
Reducing white spot lesions in orthodontic populations with fluoride rinsing. Am J Orthod Dentofacial Orthop (1992) 1.39
Congo virus: a hitherto undescribed virus occurring in Africa. I. Human isolations--clinical notes. East Afr Med J (1967) 1.39